Story

AT&T Options Market Braces for 4.3% Swing on July 22 Earnings

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
AT&T Options Market Braces for 4.3% Swing on July 22 Earnings

Summary

Options traders are pricing in a potential 4.3% post-earnings move for AT&T Inc. stock, according to Bloomberg data. The telecommunications giant is set to report its latest financial results before the market opens on July 22.

Text size
Background

The options market is anticipating a notable price swing for AT&T Inc. (NYSE:T) shares following its upcoming earnings announcement on July 22. Traders are pricing in a potential move of 4.3% in either direction, according to options data compiled by Bloomberg.

Historical Volatility

This implied move serves as a benchmark for expected volatility, but AT&T's stock has often been less volatile than anticipated on earnings day. Over the past eight quarters, the company's shares have exceeded the options-implied move on only two occasions, Bloomberg data shows.

Key historical moves include:

  • January 27, 2025: The stock moved 8.3%, more than double the 4.1% implied move.
  • October 23, 2024: Shares moved 4.6%, slightly ahead of the 4.1% implied move.
  • April 22, 2026: In its most recent report, the stock moved just 1.4%, significantly underperforming the 4.3% implied move.
Sample IUX Markets – In-articleAd

Context for Investors

The implied move is derived from the pricing of options contracts and reflects market expectations for stock volatility, not the direction of the price change. A higher implied move suggests traders are anticipating a more significant reaction to the earnings news, which can be influenced by uncertainty around key metrics like subscriber growth, free cash flow, and debt reduction progress.

While the options market provides a gauge of sentiment, the actual stock performance will depend on the financial results and management's outlook provided in the pre-market release. In six of the last eight reports, AT&T's stock reaction was more muted than what options traders had priced in.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST